Tag: Indian FDA
CDSCO approves first autologous dendritic cell-based immuno-oncology product
APAC Biotech was granted with a commercial license by CDSCO to market its product, APCEDEN, a dendritic cell-based autologous immuno-oncology product for four cancer indications....